挪威创伤登记中创伤患者围创伤期阿片类药物使用的多状态模型
本研究基于挪威创伤登记2015-2018年队列(n=24 224)链接处方数据库,构建围创伤期阿片使用多状态模型。创伤后阿片处方主要因短期使用而增加,峰值38.2%,6个月内回落至伤前5.4%;长期使用仅由4.3%升至6.7%。伤后1年长期使用患者中47.4%伤前6个月已长期使用,36.0%有慢性疼痛报销码。
要点
- 创伤后阿片处方增加主要来自短期使用,6个月内回落至伤前水平。
- 伤后长期阿片使用患者中近半数伤前已长期使用。
- 长期使用患者仅少数接受姑息或阿片替代治疗,慢性疼痛是主要指征。
核心结论
- 创伤后长期阿片使用多数患者伤前已有阿片使用,需关注伤前用药以最小化创伤后长期使用。
- 长期使用患者中仅少数因姑息治疗或阿片替代治疗,亚急性和慢性疼痛是主要指征。
研究设计与样本
- 基于人群的队列研究,链接挪威创伤登记2015-2018年队列(n=24 224)与挪威处方数据库伤前1年及伤后2年门诊处方记录。
- 长期阿片使用定义为90天内累计≥900吗啡毫克当量且初始处方后91-180天再次获得阿片处方,连续180天无阿片处方、移民或死亡则终止。
主要发现
- 创伤后阿片处方主要因短期使用增加,峰值38.2%,6个月内回落至伤前5.4%。
- 长期阿片使用由伤前4.3%升至伤后6.7%。
- 伤后1年长期使用患者(n=1946)中47.4%伤前6个月已长期使用,18.3%为短期使用。
- 长期使用患者中36.0%有慢性疼痛药物报销码,5.9%有姑息治疗报销码,13.1%接受阿片替代治疗。
关键数值与推荐
- 长期阿片使用判定:90天内≥900吗啡毫克当量且初始处方后91-180天再次获得阿片处方。
- 长期使用终止:连续180天无阿片处方、移民或死亡。
临床怎么用
- 围创伤期应评估患者伤前阿片使用史,以识别长期使用高风险者。
- 对长期阿片使用患者应关注慢性疼痛管理,考虑有效非阿片替代方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies document high rates of long-term opioid use (LTU) among trauma patients, without accounting for opioid prescription doses, frequency, and medical indications. Using detailed LTU criteria, this study aimed to construct a multistate model of peritraumatic opioid use and elucidate reasons for posttraumatic LTU. METHODS: This population-based cohort study links data from the 2015-2018 cohorts in the Norwegian Trauma Registry (n=24 224) with outpatient medication prescription records from the Norwegian Prescription Database for 1 yr before and 2 yr after injury. LTU was assigned upon receiving ≥900 morphine milligram equivalents within 90 days and another opioid prescription 91-180 days after any initial prescription; it ended after 180 days without opioid prescriptions, emigration, or death. Prescriptions to patients with LTU in the year after injury were screened for chronic pain and palliative care reimbursement codes, and for opioid maintenance treatment preparations. RESULTS: Posttraumatic opioid prescriptions primarily increased as a result of short-term opioid use (STU), peaking at 38.2% and returning to pre-injury levels (5.4%) within 6 months. Increases in LTU were smaller (4.3% to 6.7%). Among patients with LTU in the year after injury (n=1946), 47.4% exhibited LTU and 18.3% STU in the 6 months pre-injury. Moreover, 36.0% were reimbursed for chronic pain medications, 5.9% for palliative care, and 13.1% received opioid maintenance treatment. CONCLUSIONS: In our cohort, most patients with posttraumatic long-term opioid use had used opioids before injury, underscoring the need to address such use to minimise posttraumatic long-term opioid use. Few patients with long-term opioid use received palliative care or opioid maintenance treatment, indicating subacute and chronic pain as primary indications. As long-term opioid use for pain is highly controversial, findings emphasise a need for effective nonopioid alternatives.
引用
- Engel S, Rosseland LA, Smits M, et al. Population-based multistate modelling of peritraumatic opioid use among trauma patients from the Norwegian Trauma Registry. Br J Anaesth. 2025. PMID: 40615331. doi:10.1016/j.bja.2025.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。